NO20064892L - Heterosykliske fenylpropan-2-olderivater og relaterte forbindelser som modulatorer av norepinefrin (NE) og serotonin (5-HT) aktivitet og monoamin-gjenopptak for behandling av - Google Patents

Heterosykliske fenylpropan-2-olderivater og relaterte forbindelser som modulatorer av norepinefrin (NE) og serotonin (5-HT) aktivitet og monoamin-gjenopptak for behandling av

Info

Publication number: NO20064892L
Authority: NO; Norway
Prior art keywords: disorders; derivatives; monoamine reuptake; phenylpropane; norepinephrine
Prior art date: 2004-03-30

Application number

NO20064892A

Other languages

English (en)

Norwegian (no)

Inventor

Paige Erin Mahaney

Puwen Zhang

Callain Younghee Kim

Stephen Todd Cohn

Eugene John Trybulski

Joseph Peter Sabatucci

An Thien Vu

Fei Ye

Eugene Anthony Terefenko

Casey Cameron Mccomas

Michael Anthony Marella

Richard Dale Coghlan

Gavin David Heffernan

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-30

Filing date

2006-10-26

Publication date

2006-12-13

2006-10-26 Application filed by Wyeth Corp filed Critical Wyeth Corp

2006-12-13 Publication of NO20064892L publication Critical patent/NO20064892L/no

Links

125000000623 heterocyclic group Chemical group 0.000 title abstract 2
230000000407 monoamine reuptake Effects 0.000 title abstract 2
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 4
SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 title 2
229960002748 norepinephrine Drugs 0.000 title 2
SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 title 2
150000001875 compounds Chemical class 0.000 title 1
230000000694 effects Effects 0.000 title 1
229940076279 serotonin Drugs 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
208000035475 disorder Diseases 0.000 abstract 3
208000024891 symptom Diseases 0.000 abstract 2
230000001457 vasomotor Effects 0.000 abstract 2
WXMQDCRVBPMUBV-UHFFFAOYSA-N 1-anilinopropan-1-ol Chemical class CCC(O)NC1=CC=CC=C1 WXMQDCRVBPMUBV-UHFFFAOYSA-N 0.000 abstract 1
206010008874 Chronic Fatigue Syndrome Diseases 0.000 abstract 1
208000020401 Depressive disease Diseases 0.000 abstract 1
208000032131 Diabetic Neuropathies Diseases 0.000 abstract 1
208000001640 Fibromyalgia Diseases 0.000 abstract 1
208000012902 Nervous system disease Diseases 0.000 abstract 1
208000002193 Pain Diseases 0.000 abstract 1
201000001880 Sexual dysfunction Diseases 0.000 abstract 1
206010046543 Urinary incontinence Diseases 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
235000019788 craving Nutrition 0.000 abstract 1
230000002496 gastric effect Effects 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
125000006413 ring segment Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
231100000872 sexual dysfunction Toxicity 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
208000011580 syndromic disease Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20064892A 2004-03-30 2006-10-26 Heterosykliske fenylpropan-2-olderivater og relaterte forbindelser som modulatorer av norepinefrin (NE) og serotonin (5-HT) aktivitet og monoamin-gjenopptak for behandling av NO20064892L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US55765104P	2004-03-30	2004-03-30
US56986304P	2004-05-11	2004-05-11
US11/091,885 US7517899B2 (en)	2004-03-30	2005-03-28	Phenylaminopropanol derivatives and methods of their use
PCT/US2005/010511 WO2005097744A1 (en)	2004-03-30	2005-03-29	1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms)

Publications (1)

Publication Number	Publication Date
NO20064892L true NO20064892L (no)	2006-12-13

Family

ID=34964018

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20064892A NO20064892L (no)	2004-03-30	2006-10-26	Heterosykliske fenylpropan-2-olderivater og relaterte forbindelser som modulatorer av norepinefrin (NE) og serotonin (5-HT) aktivitet og monoamin-gjenopptak for behandling av

Country Status (20)

Country	Link
US (3)	US7517899B2 (de)
EP (1)	EP1732887B1 (de)
JP (1)	JP2007531751A (de)
KR (1)	KR20060134186A (de)
AR (1)	AR048675A1 (de)
AT (1)	ATE383337T1 (de)
AU (1)	AU2005230900A1 (de)
BR (1)	BRPI0509390A (de)
CA (1)	CA2560967A1 (de)
CR (1)	CR8639A (de)
DE (1)	DE602005004268T2 (de)
DK (1)	DK1732887T3 (de)
EC (1)	ECSP066899A (de)
ES (1)	ES2299025T3 (de)
IL (1)	IL178185A0 (de)
NO (1)	NO20064892L (de)
PE (1)	PE20060288A1 (de)
PL (1)	PL1732887T3 (de)
TW (1)	TW200536532A (de)
WO (1)	WO2005097744A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7414052B2 (en) *	2004-03-30	2008-08-19	Wyeth	Phenylaminopropanol derivatives and methods of their use
WO2005118539A1 (en) *	2004-06-01	2005-12-15	F.Hoffmann-La Roche Ag	3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
AU2006242542A1 (en) *	2005-04-29	2006-11-09	Wyeth	Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
US7687529B2 (en) *	2005-09-29	2010-03-30	Wyeth Llc	Substituted propylamine derivatives and methods of their use
JP2009510066A (ja) *	2005-09-29	2009-03-12	ワイス	血管運動症状（ｖｍｓ）の治療のためのモノアミン再取り込みのモジュレータである１−（１ｈ−インドール−１−イル）−３−（メチルアミノ）−１−フェニルプロパン−２−オール誘導体および関連の化合物
BRPI0619263A2 (pt) *	2005-11-30	2011-09-27	Hoffmann La Roche	indóis de 3-amino-1-arilpropila e indóis aza-substituìdos, métodos para prepará-los, composição farmacêutica e uso dos referidos indóis
CA2632284A1 (en) *	2005-11-30	2007-06-07	F. Hoffmann-La Roche Ag	3-amino-2-arylpropyl azaindoles and uses thereof
CA2631048A1 (en)	2005-11-30	2007-06-07	F. Hoffmann-La Roche Ag	Methods for synthesis of 3-amino-1-arylpropyl indoles
CL2007002449A1 (es) *	2006-08-24	2008-03-07	Wyeth Corp	Compuestos derivados de indolinona fenilaminopropanol; composicion farmaceutica; procedimiento de preparacion de dichos compuestos, utiles en disfuncion sexual, trastornos gastrointestinales y genitourinarios, fibromialgia, fatiga cronica, trastornos
US7671238B2 (en) *	2006-10-04	2010-03-02	Wyeth Llc	Arylamino-arylpropanolamine derivatives and methods of their use
HUP1000598A2 (en)	2010-11-05	2012-09-28	Richter Gedeon Nyrt	Indole derivatives
EP2665707B1 (de) *	2011-01-20	2017-01-18	Merck Sharp & Dohme Corp.	Mineralkortikoid-rezeptorantagonisten
EP2875013B1 (de) *	2012-07-17	2017-11-29	Glaxosmithkline Intellectual Property (No. 2) Limited	Indolcarbonitrile als selektive androgenrezeptormodulatoren
KR101460738B1 (ko) *	2012-08-23	2014-11-12	한국과학기술연구원	신규한 2-나프틸 프로판-2-올 화합물, 이를 포함하는 약학 조성물, 및 상기 약학 조성물을 포함하는 제제
JOP20200344A1 (ar)	2018-07-03	2020-12-31	Univ Illinois	منشطات لاستجابة البروتين غير المطوي
US20220296604A1 (en) *	2019-08-08	2022-09-22	New York University	Indole compounds as modulators of rage activity and uses thereof
CN114539080A (zh) *	2022-03-02	2022-05-27	八叶草健康产业研究院(厦门)有限公司	一种2-(2-氨基-6-氯苯基)-乙酸钠的制备方法
WO2024158872A1 (en) *	2023-01-25	2024-08-02	The Rockefeller University	1,3-indole-propanamide inhibitors of sars-cov-2 plpro/nsp3 and derivatives thereof

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3454554A (en)	1960-10-14	1969-07-08	Colgate Palmolive Co	Aminoalkyliminodibenzyl compounds
US4123543A (en)	1971-09-16	1978-10-31	Ab Kabi	Derivatives of substituted indoline lactans with effect on the central nervous system
CS175831B1 (de)	1974-12-17	1977-05-31
IL56369A (en)	1978-01-20	1984-05-31	Erba Farmitalia	Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
US4310524A (en)	1980-04-11	1982-01-12	Richardson-Merrell, Inc.	TCA Composition and method for rapid onset antidepressant therapy
PH18686A (en)	1981-05-26	1985-08-29	Merck & Co Inc	1-(3 halo-2-pyridinyl) piperazine
US4535186A (en)	1983-04-19	1985-08-13	American Home Products Corporation	2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
EP0135905A3 (de)	1983-09-29	1986-10-22	ASTA Pharma Aktiengesellschaft	Neue 1-(Alkyl-hydroxy-phenyl)-1-hydroxy-2-(alkylamino)-propane
CA1280421C (en)	1985-07-02	1991-02-19	Albert A. Carr	1,4-disubstituted piperidinyl derivatives
ZA885824B (en)	1987-08-14	1989-04-26	Merrell Dow Pharma	Novel antidepressants
US4826844A (en)	1987-09-30	1989-05-02	American Home Products Corporation	Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
CA2083698C (en)	1990-06-01	1997-11-04	Albert A. Carr	(+)-alpha-(2,3-dimethoxyphenyl)-1- [2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
US5648511A (en)	1990-11-19	1997-07-15	G.D. Searle & Co.	Method for making intermediates useful in the synthesis of retroviral protease inhibitors
FR2686878B1 (fr)	1992-01-30	1995-06-30	Sanofi Elf	Derives du n-sulfonyl oxo-2 indole, leur preparation, les compositions pharmaceutiques en contenant.
FR2708605A1 (fr)	1993-07-30	1995-02-10	Sanofi Sa	Dérivés du N-sulfonylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
US5502047A (en)	1993-03-22	1996-03-26	Kavey; Neil B.	Treatment for insomnia
US5516774A (en)	1993-07-29	1996-05-14	American Cyanamid Company	Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
FR2708606B1 (fr)	1993-07-30	1995-10-27	Sanofi Sa	Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
FR2714378B1 (fr)	1993-12-24	1996-03-15	Sanofi Sa	Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
AU3414295A (en)	1994-08-19	1996-03-14	Nps Pharmaceuticals, Inc.	Methods and compounds active at metabotropic glutamate receptors useful for treatment of neurological disorders and diseases
AU5857296A (en)	1995-05-17	1996-11-29	Eli Lilly And Company	Use of leukotriene antagonists for alzheimer's disease
FR2740136B1 (fr)	1995-10-24	1998-01-09	Sanofi Sa	Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
GB9606016D0 (en)	1996-03-22	1996-05-22	Smithkline Beecham Plc	Novel use
UA48219C2 (uk)	1996-03-25	2002-08-15	Елі Ліллі Енд Компані	Композиція для вгамування болю (варіанти) та спосіб вгамування болю
WO1998014208A1 (en)	1996-09-30	1998-04-09	President And Fellows Of Harvard College	Reactive ligands and covalent ligand-protein complexes
FR2757157B1 (fr)	1996-12-13	1999-12-31	Sanofi Sa	Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
CA2321648A1 (en)	1998-03-02	1999-09-10	Hunter Heath Iii	Fluoxetine hydrochloride for decreasing hot flashes
TW528754B (en)	1998-04-29	2003-04-21	Wyeth Corp	Indolyl derivatibes as serotonergic agents
WO2000002551A2 (en)	1998-07-13	2000-01-20	Nps Pharmaceuticals, Inc.	Methods and compounds for treating depression
PL350924A1 (en)	1999-04-06	2003-02-10	Sepracor Inc	Derivatives of venlafaxine and methods of preparing and using the same
US6329416B1 (en)	1999-05-04	2001-12-11	American Home Products Corporation	Combination regimens using 3,3-substituted indoline derivatives
US6391907B1 (en)	1999-05-04	2002-05-21	American Home Products Corporation	Indoline derivatives
DE60035232T2 (de)	1999-07-01	2008-02-14	Pharmacia & Upjohn Co. Llc, Kalamazoo	(S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom
FR2804114B1 (fr)	2000-01-25	2002-03-08	Sanofi Synthelabo	Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
FR2804115B1 (fr)	2000-01-25	2002-03-08	Sanofi Synthelabo	Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
EP1272483A2 (de)	2000-03-24	2003-01-08	Millenium Pharmaceuticals, Inc.	Oxindole als faktor xa inhibitoren
US20030008860A1 (en)	2002-05-09	2003-01-09	Bakker-Arkema Rebecca Guggemos	Treatment of congestive heart failure
GB2362826A (en)	2000-06-02	2001-12-05	Lilly Co Eli	A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
US6846813B2 (en)	2000-06-30	2005-01-25	Pharmacia & Upjohn Company	Compounds to treat alzheimer's disease
AU9087301A (en)	2000-09-11	2002-03-26	Sepracor Inc	Ligands for monoamine receptors and transporters, and methods of use thereof
DE60221642T3 (de)	2001-02-12	2017-10-26	Wyeth LLC (n.d.Ges.d. Staates Delaware)	O-desmethyl-venlafaxine succinat salz
CA2442410A1 (en)	2001-03-29	2002-10-10	Owen Brendan Wallace	Duloxetine for treatment of hot flashes
EP1266659A1 (de)	2001-06-11	2002-12-18	Pantarhei Bioscience B.V.	Pyridoxal im Verbindung mit Serotonine-hebenhemmer für die Behandlung des heissen Errötens
WO2003010169A1 (en)	2001-07-25	2003-02-06	Wyeth	Antidepressant azaheterocyclylmethyl derivatives of 7, 8-dihydro-6h-5-oxa-1-aza-phenanthrene
WO2004089942A2 (en)	2001-10-02	2004-10-21	Acadia Pharmaceuticals Inc.	Benzimidazolidinone derivatives as muscarinic agents
WO2003037334A1 (en)	2001-10-31	2003-05-08	Merck & Co., Inc.	Method for treating or preventing symptoms of hormonal variation including hot flashes
US6602911B2 (en)	2001-11-05	2003-08-05	Cypress Bioscience, Inc.	Methods of treating fibromyalgia
JP2005526079A (ja)	2002-03-15	2005-09-02	サイプレスバイオサイエンス，インコーポレイテッド	内蔵痛症候群を処置するためのｎｅおよび５−ｈｔ再取り込み阻害剤
TW200402289A (en)	2002-05-17	2004-02-16	Wyeth Corp	Methods of treating gastrointestinary and genitourinary pain disorders
BR0313411A (pt)	2002-08-14	2005-06-28	Pharmacia & Upjohn Co Llc	Uso de reboxetina para o tratamento de ondas de calor
US7345096B2 (en)	2002-10-15	2008-03-18	Wyeth	Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US20040180879A1 (en)	2002-10-15	2004-09-16	Deecher Darlene Coleman	Novel method of treating vasomotor symptoms
US20040152710A1 (en)	2002-10-15	2004-08-05	Deecher Darlene Coleman	Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7524846B2 (en) *	2003-10-14	2009-04-28	Wyeth	Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US7491723B2 (en) *	2003-10-14	2009-02-17	Wyeth	Alkanol and cycloalkanol-amine derivatives and methods of their use
US7419980B2 (en) *	2003-10-14	2008-09-02	Wyeth	Fused-aryl and heteroaryl derivatives and methods of their use
US20050130987A1 (en)	2003-10-14	2005-06-16	Wyeth	Methods of treating vasomotor symptoms
US7531543B2 (en) *	2003-10-14	2009-05-12	Wyeth	Phenylpiperazine cycloalkanol derivatives and methods of their use
US7365076B2 (en) *	2003-10-14	2008-04-29	Wyeth	Substituted aryl cycloalkanol derivatives and methods of their use
US7550485B2 (en) *	2003-10-14	2009-06-23	Wyeth	Substituted N-heterocycle derivatives and methods of their use
US20050165082A1 (en) *	2003-12-16	2005-07-28	Wyeth	Methods of treating vasomotor symptoms
US7414052B2 (en) *	2004-03-30	2008-08-19	Wyeth	Phenylaminopropanol derivatives and methods of their use

2005
- 2005-03-28 US US11/091,885 patent/US7517899B2/en not_active Expired - Fee Related
- 2005-03-29 AT AT05730271T patent/ATE383337T1/de not_active IP Right Cessation
- 2005-03-29 DE DE602005004268T patent/DE602005004268T2/de not_active Expired - Fee Related
- 2005-03-29 BR BRPI0509390-2A patent/BRPI0509390A/pt not_active IP Right Cessation
- 2005-03-29 AU AU2005230900A patent/AU2005230900A1/en not_active Withdrawn
- 2005-03-29 WO PCT/US2005/010511 patent/WO2005097744A1/en not_active Ceased
- 2005-03-29 EP EP05730271A patent/EP1732887B1/de not_active Expired - Lifetime
- 2005-03-29 TW TW094109747A patent/TW200536532A/zh unknown
- 2005-03-29 DK DK05730271T patent/DK1732887T3/da active
- 2005-03-29 KR KR1020067022665A patent/KR20060134186A/ko not_active Withdrawn
- 2005-03-29 CA CA002560967A patent/CA2560967A1/en not_active Abandoned
- 2005-03-29 ES ES05730271T patent/ES2299025T3/es not_active Expired - Lifetime
- 2005-03-29 JP JP2007506469A patent/JP2007531751A/ja not_active Withdrawn
- 2005-03-29 PL PL05730271T patent/PL1732887T3/pl unknown
- 2005-03-30 AR ARP050101217A patent/AR048675A1/es unknown
- 2005-03-30 PE PE2005000365A patent/PE20060288A1/es not_active Application Discontinuation
2006
- 2006-09-19 IL IL178185A patent/IL178185A0/en unknown
- 2006-09-20 CR CR8639A patent/CR8639A/es not_active Application Discontinuation
- 2006-09-29 EC EC2006006899A patent/ECSP066899A/es unknown
- 2006-10-26 NO NO20064892A patent/NO20064892L/no not_active Application Discontinuation
2008
- 2008-12-15 US US12/335,245 patent/US20090093469A1/en not_active Abandoned
- 2008-12-15 US US12/335,144 patent/US20090099164A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1732887B1 (de)	2008-01-09
JP2007531751A (ja)	2007-11-08
PE20060288A1 (es)	2006-05-23
DK1732887T3 (da)	2008-04-28
ES2299025T3 (es)	2008-05-16
EP1732887A1 (de)	2006-12-20
KR20060134186A (ko)	2006-12-27
ECSP066899A (es)	2006-11-24
CA2560967A1 (en)	2005-10-20
IL178185A0 (en)	2006-12-31
AU2005230900A1 (en)	2005-10-20
BRPI0509390A (pt)	2007-09-18
US20090093469A1 (en)	2009-04-09
TW200536532A (en)	2005-11-16
DE602005004268T2 (de)	2009-01-02
ATE383337T1 (de)	2008-01-15
DE602005004268D1 (de)	2008-02-21
PL1732887T3 (pl)	2008-05-30
AR048675A1 (es)	2006-05-17
US20050222148A1 (en)	2005-10-06
WO2005097744A1 (en)	2005-10-20
US7517899B2 (en)	2009-04-14
CR8639A (es)	2007-06-08
US20090099164A1 (en)	2009-04-16

Legal Events

Date	Code	Title	Description
2008-10-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20064892L (no)	2006-12-13	Heterosykliske fenylpropan-2-olderivater og relaterte forbindelser som modulatorer av norepinefrin (NE) og serotonin (5-HT) aktivitet og monoamin-gjenopptak for behandling av
NO20085385L (no)	2008-12-29	Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav
NO20073019L (no)	2007-09-27	Pyrasolonforbindelser som metabotrope glutamatreseptor-antagonister for behandlingen av nevrotiske og psykiatriske lidelser
EA200801934A1 (ru)	2009-02-27	1,4-двузамещённые 3-циано-пиридоновые производные и их применение в качестве позитивных модуляторов рецепторов mglur2
EA200700617A1 (ru)	2007-10-26	Новые пиридиновые производные и их применение в качестве позитивных аллостерических модуляторов mglur2-рецепторов
NO20063298L (no)	2006-09-14	Benzensulfonylamino-pyridin-2-yl-derivater og beslektede forbindelser som inhibitorer for 11-beta-hydroksy steroid dehydrogenase type 1(11-beta-hsd-1) for behandling av diabetes og fedme
NO20084302L (no)	2008-12-03	2-(syklisk amino)-pyrimidonderivater som TPK1-inhibitorer
BRPI0510365A (pt)	2007-11-06	composto, método de produção de um composto, antagonista do receptor nk2, pró-droga, agente farmacêutico, métodos para antagonizar um recpetor nk2 e para evitar ou tratar doenças gastrintestinais funcionais, e, uso do composto ou uma pró-droga do mesmo
PE20071009A1 (es)	2007-10-24	Compuestos derivados de fenoxipiperidinas como antagonistas de histamina h3
NO20070583L (no)	2007-03-08	Isoindolonforbindelser og anvendelse derav som metabotrofe glutamatreseptorforsterker
EA200970612A1 (ru)	2009-10-30	Производные индола в качестве агонистов рецептора s1p1
NO20076479L (no)	2008-01-29	Nye oksadiazolderivater og anvendelse derav som positive allosteriske metabotropiske modulatorer av glutamatreseptorer
MX2012007273A (es)	2012-12-17	Pteridinonas como inhibidores de la quinasa tipo polo.
EA201000332A1 (ru)	2010-10-29	1,3-двузамещенные 4-фенил-1н-пиридин-2-оны
WO2008108380A3 (en)	2009-04-16	Pyrrole compounds
EA200901159A1 (ru)	2010-04-30	Производные 3-циано-4-(4-фенилпиперидин-1-ил)пиридин-2-она
NO20085140L (no)	2009-03-06	Nye indazolderivater som har spiro ringstruktur i sidekjede
EA201001595A1 (ru)	2011-04-29	Соединения и композиции в качестве модуляторов активности gpr119
TW200718692A (en)	2007-05-16	Dihydrobenzofuran derivatives and uses thereof
WO2009057811A3 (en)	2009-07-09	Heterocyclic compound and pharmaceutical composition thereof
JO3098B1 (ar)	2017-03-15	مركبات داي فينيل- بيرازول بيريدين وطريقة تحضيرها واستخدامها كمعدلات المستقبل النووي not
TW200719886A (en)	2007-06-01	Dihydrobenzofuran derivatives and uses thereof
NO20092092L (no)	2009-08-19	Arylsulfamidderivater og fremgangsmater for anvendelse derav
EA200701583A1 (ru)	2008-04-28	Гетероциклические тетрациклические производные гидрофурана в качестве ингибиторов 5нт2 в терапии расстройств цнс
MX2011009700A (es)	2011-12-08	Derivado de amida.